Portfolio News
- October 29, 2008 Alvine Pharmaceuticals Reports Positive Results with ALV003 in Phase 1 Trial of Therapy in Development for Celiac Disease
- October 28, 2008 Phenomix Initiates Phase 1a Clinical Trial of Hepatitis C Protease Inhibitor PHX1766
- October 28, 2008 Corticon and KXEN Partner to Provide Intelligent Decision Management
- October 28, 2008 Catalyst Biosciences Appoints Dr. Todd Lorenz Chief Medical Officer
- October 24, 2008 Seattle Genetics Presents Preclinical Data on Antibody-Drug Conjugate Programs
- October 22, 2008 Threshold Pharmaceuticals Presents Encouraging Additional Preliminary Findings From a Phase 1 Clinical Trial of TH-302 for Solid Tumors
- October 22, 2008 Trius Awarded $28 Million Contract to Develop Novel Antibiotics
- October 21, 2008 China Mobile selects Streamezzo to develop and deploy interactive mobile TV offering in time for 2008 Olympics
- October 20, 2008 Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA
- October 16, 2008 InterMune Reports Japanese Regulatory Approval of Pirfenidone in IPF